Author:
Budd Jeffrey,Cusi Kenneth
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference91 articles.
1. Paik JM, Henry L, De Avila L, Younossi E, Racila A, Younossi ZM. Mortality related to nonalcoholic fatty liver disease is increasing in the United States. Hepatol Commun. 2019;3(11):1459–71.
2. •• Akshintala D, Chugh R, Amer F, Cusi K. Nonalcoholic fatty liver disease: the overlooked complication of type 2 diabetes. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–2019. NBK544043 [bookaccession]. This review emphasizes the severe metabolic, cardiovascular and liver-specific complications of NAFLD in patients with T2DM.
3. • Cusi K. A diabetologist’s perspective of non-alcoholic steatohepatitis (NASH): knowledge gaps and future directions. Liver Int. 2020;40(Suppl 1):82–8 This review identifies knowledge gaps and potential future paths in the treatment of NASH in the context of T2DM.
4. Cusi K. Time to include nonalcoholic steatohepatitis in the management of patients with type 2 diabetes. Diabetes Care. 2020;43(2):275–9.
5. Stefan N, Roden M. Diabetes and fatty liver. Exp Clin Endocrinol Diabetes. 2019;127(Suppl 1):S93–6.
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献